BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 23784867)

  • 1. Amniotic fluid glial fibrillary acidic protein (AF-GFAP), a biomarker of open neural tube defects.
    Lopez J; Mikaelian I; Gonzalo P
    Prenat Diagn; 2013 Oct; 33(10):990-5. PubMed ID: 23784867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of glial fibrillary acidic protein determination in amniotic fluid for prenatal diagnosis of neural tube defects.
    Van Regemorter N; Gheuens J; Noppe M; Vamos E; Seller MJ; Lowenthal A
    Clin Chim Acta; 1987 May; 165(1):83-8. PubMed ID: 2440621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Assessment of AFP in amniotic fluid: comparison of three automated techniques].
    Leguy MC; Tavares Sdos R; Tsatsaris V; Lewin F; Clauser E; Guibourdenche J
    Ann Biol Clin (Paris); 2011; 69(4):441-6. PubMed ID: 21896409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antenatal detection of neural tube defects: comparison of biochemical and immunofluorescence methods.
    Bell JE; Barron L; Raab G
    Prenat Diagn; 1994 Jul; 14(7):615-22. PubMed ID: 7526368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amniotic fluid acetylcholinesterase electrophoresis as a secondary test in the diagnosis of anencephaly and open spina bifida in early pregnancy. Report of the Collaborative acetylcholinesterase Study.
    Lancet; 1981 Aug; 2(8242):321-4. PubMed ID: 6115108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Routine measurement of amniotic fluid alpha-fetoprotein and acetylcholinesterase: the need for a reevaluation.
    Flick A; Krakow D; Martirosian A; Silverman N; Platt LD
    Am J Obstet Gynecol; 2014 Aug; 211(2):139.e1-6. PubMed ID: 24530818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prenatal diagnosis of neural tube defects. II. Analysis of false positive and false negative alpha-fetoprotein results.
    Milunsky A; Alpert E
    Obstet Gynecol; 1976 Jul; 48(1):6-12. PubMed ID: 59328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of amniotic fluid alpha-fetoprotein and acetylcholinesterase in the prenatal diagnosis of open neural tube defects and anterior abdominal wall defects.
    Loft AG; Høgdall E; Larsen SO; Nørgaard-Pedersen B
    Prenat Diagn; 1993 Feb; 13(2):93-109. PubMed ID: 7681980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Increased AFP in maternal serum as an indication for invasive diagnosis].
    Gremm B; Sohn C; Beldermann F; Bastert G
    Zentralbl Gynakol; 1997; 119(11):560-6. PubMed ID: 9480612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amniotic fluid alpha-fetoprotein as a marker in prenatal diagnosis of neural tube defects.
    Weiss RR; Macri JN; Elligers K; Princler GL; McIntire R; Waldman TA
    Obstet Gynecol; 1976 Feb; 47(2):148-51. PubMed ID: 55990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prenatal diagnosis of open neural tube defects using the amniotic fluid acetylcholinesterase assay.
    Milunsky A; Sapirstein VS
    Obstet Gynecol; 1982 Jan; 59(1):1-5. PubMed ID: 6176922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Routine amniotic fluid alphafetoprotein assay: experience with 40,000 pregnancies.
    Crandall BF; Matsumoto M
    Am J Med Genet; 1986 May; 24(1):143-9. PubMed ID: 2422932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal diagnosis of neural tube defects: experiences with acetylcholinesterase gel electrophoresis.
    Crandall BF; Kasha W; Matsumoto M
    Am J Med Genet; 1982 Jul; 12(3):361-6. PubMed ID: 6180640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunocytochemical characterization of amniotic fluid macrophages in cases of fetal neural tube defects.
    Polgar K; Abel G; Laczko J; Sipka S; Papp Z
    Am J Clin Pathol; 1987 Jan; 87(1):37-42. PubMed ID: 2432773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of amniotic acetylcholinesterase analysis in the diagnosis of fetal abnormality in 3700 pregnancies.
    Aitken DA; Morrison NM; Ferguson-Smith MA
    Prenat Diagn; 1984; 4(5):329-40. PubMed ID: 6209698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amniotic fluid test for the diagnosis of neural tube defects.
    Lituania M; Canini S; Cordone M; Lenzi A
    J Nucl Med Allied Sci; 1989; 33(3 Suppl):63-6. PubMed ID: 2480426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Biochemical markers of neural tube closure defects during the second half of pregnancy].
    Guibaud S; Boisson C; Simplot A; Thoulon JM
    J Genet Hum; 1988 Aug; 36(4):337-46. PubMed ID: 2464664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amniotic fluid acetylcholinesterase measurement in the prenatal diagnosis of open neural tube defects. Second report of the Collaborative Acetylcholinesterase Study.
    Wald N; Cuckle H; Nanchahal K
    Prenat Diagn; 1989 Dec; 9(12):813-29. PubMed ID: 2483269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amniotic Fluid Concentrations of Glial Fibrillary Acidic Protein Do Not Correlate with Prenatal Metrics in Fetuses with Myelomeningocele.
    Kim AG; Danzer E; Moldenhauer JS; Khalek N; McClain LE; Waqar LN; Hedrick HL; Johnson MP; Adzick NS; Peranteau WH; Flake AW
    Fetal Diagn Ther; 2018; 43(4):297-303. PubMed ID: 28768252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glial fibrillary acidic protein in amniotic fluids from pregnancies with fetal neural tube defects.
    Albrechtsen M; Bock E; Nørgaard-Pedersen B
    Prenat Diagn; 1984; 4(6):405-10. PubMed ID: 6522345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.